Antisoma's Shares Rise as Company Announces Acquisition of Xanthus
By The PharmaDeals Team
Pharma Deals Review: Vol 2008 Issue 96 (Table of Contents)
Published: 16 May-2008
DOI: 10.3833/pdr.v2008.i96.181 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
UK cancer biotech Antisoma is to acquire private US company Xanthus Pharmaceuticals, which develops small molecule cancer and autoimmune disorder therapeutics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS